Mantle Cell Lymphoma | Tumor

CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Managing Mantle Cell Lymphoma (MCL) after Relapsed on First Treatment

An interview with Dr. Luhua (Michael) Wang, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center

Keep Inspiring

Don’t let your disease define you

New Targeted Drugs Nearly Double Survival Time in Mantle Cell Lymphoma

July 5th 2018, 11:20pm

Article

Since its classification in 1994, the prognosis for patients diagnosed with mantle cell lymphoma (MCL) was generally poor; however, survival rates have nearly doubled thanks to improvements in the treatment landscape over the past 10 years.

Diagnosis Day Three

June 28th 2018, 10:17pm

Article

Moving from shock to action is hard, but it's critical to surviving cancer

Venclexta Shows Potential to Treat Mantle Cell Lymphoma, Unmet Needs Remain

June 25th 2018, 11:48pm

Article

Patients with mantle cell lymphoma (MCL) who were treated with Venclexta (venetoclax) showed a slight improvement in response rates compared with chemoimmunotherapy.

My Invisible Coaches

June 21st 2018, 5:56pm

Article

Sometimes the people who inspire us are closer than we realize.

Happiness Comes And Goes, But Joy Is Forever

May 18th 2018, 11:21pm

Article

Do you know the difference between happiness and joy?

Venclexta and Imbruvica Combo Shows Promise in Mantle Cell Lymphoma

May 7th 2018, 7:32pm

Article

A higher complete response rate was seen in patients given both agents compared with those given Imbruvica alone.

Expert Weighs In on What's Next for Mantle Cell Lymphoma

May 6th 2018, 10:33pm

Article

The treatment landscape of mantle cell lymphoma is continuing to change. See what expert Andre Goy, M.D., has to say about it.

FDA Approves Drug for Chronic Immune Thrombocytopenia

April 18th 2018, 5:39pm

Article

Tavalisse (fostamatinib) was granted approval by the Food and Drug Administration (FDA) for patients with chronic immune thrombocytopenia (ITP) after they had an insufficiencent response to another therapy.

Guilt Is Good, Says One Cancer Survivor

March 23rd 2018, 5:29pm

Article

Kevin unleashes his inner guilt for the benefit of you, gentle readers.

You Know You've Been to the Oncologist Too Many Times When...

November 2nd 2017, 5:44am

Article

You walk in and the entire staff yells your name, al la “Norm” of Cheers fame